Naloxegol, an Oral Peripherally Acting Opioid Receptor Antagonist, Administered Concurrently with First-Line Systemic Therapy for Advanced Lung Adenocarcinoma (Alliance A221504): A Feasibility and Safety Study
纳洛昔醇(一种口服外周作用阿片受体拮抗剂)与一线全身治疗联合用于晚期肺腺癌(Alliance A221504):一项可行性和安全性研究
期刊:Cancers
影响因子:4.4
doi:10.3390/cancers18030373
Gupta, Pankaj; Gupta, Kalpna; Dockter, Travis; Harlos, Elizabeth; Chow, Selina; Subbiah, Niveditha; Ruddy, Kathryn J; Bazhenova, Lyudmila; Terstriep, Shelby; Huang, Chao H; Kratzke, Robert A; Vokes, Everett E; Loprinzi, Charles L